EMD-26583

Single-particle
3.09 Å
EMD-26583
3D View Gallery
Deposition: 01/04/2022
Map released: 04/10/2023
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-26583

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7ukl summary report (pdf.gz) Map-7ukl FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Cryo-EM structure of Antibody 12-16 in complex with prefusion SARS-CoV-2 Spike glycoprotein

EMD-26583

Single-particle
3.09 Å
EMD-26583
3D View Gallery
Deposition: 01/04/2022
Map released: 04/10/2023
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: Antibody 12-16 in complex with prefusion SARS-CoV-2 Spike glycoprotein
Fitted models: 7ukl

Deposition Authors: Casner RG, Shapiro L
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking.
Liu L , Casner RG, Guo Y , Wang Q, Iketani S , Chan JF, Yu J, Dadonaite B, Nair MS, Mohri H, Reddem ER, Yuan S , Poon VK, Chan CC, Yuen KY, Sheng Z, Huang Y, Bloom JD, Shapiro L, Ho DD
(2023) Immunity , 56 , 2442
PUBMED: 37776849
DOI: doi:10.1016/j.immuni.2023.09.003
ISSN: 1074-7613
ASTM: IUNIEH
Grant Support: